Search - tctmd.com

Displaying 481 - 500 of 1581

Sort: Relevancy | Date

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

Overcoming the "Credibility Crisis" of Observational Data

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Presenter: Samir Kapadia

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

The FDA Total lifecycle Advisory Program (FDA-TAP)

Presenter: April Marrone

October 24, 2023

Presentation TCT 2023

Understanding the New Technology Add-on Payments Program (NTAP)

Presenter: Dominic Allocco

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

Presenter: Steven Farmer

October 24, 2023

Presentation TCT 2023

TCT 725: Blinded 3D Computational Modeling Derived Peak Areal Stretch from Pre-TAVR CT Is Predictive of Aortic Root Rupture Post TAVR

Presenter: Taylor SBecker

October 24, 2023

Presentation TCT 2023

TCT 671: Comparison of Biological and Polymeric Transcatheter Aortic Valves in an Ovine, Aortic Banding Model

Presenter: Karolina Lukasik

October 24, 2023

Presentation TCT 2023

Precision Measurement of Neurocognitive Health Based on Ocular Digital Phenotyping

Presenter: Mark Edwards

October 24, 2023

Presentation TCT 2023

What Should EFS 2.0 Look Like?

Presenter: Aaron Kaplan

October 24, 2023

Presentation TCT 2023

TCT 467: DurAVR Biomimetic Transcatheter Aortic Valve: First-In-Human Study Results Update

Presenter: NULL

October 24, 2023

Presentation TCT 2023

Cognitive AI and Computer Vision to Detect Acute Cardiac Conditions Using Facial Analysis (MiaVitalis)

Presenter: Issam Moussa

October 24, 2023

Presentation TCT 2023

MDIC and EFS: The Good, the Bad, and the Ugly (Case Examples)

Presenter: Chip Hance

October 24, 2023

Presentation TCT 2023

TCT 374: Redo Transcatheter Aortic Valve Replacement With the Novel DurAVR Valve: Insights From the Bench

Presenter: Stephanie Sellers

October 24, 2023

Presentation TCT 2023

Viewpoints From Europe

Presenter: Stephan Windecker

October 24, 2023

Presentation TCT 2023

TCT 262: Rejuvenate: A Novel Anti-Calcific and Anti-Thrombotic Polymeric TAVR With Adaptive Sealing Technology

Presenter: Srujana Joshi

October 24, 2023

Presentation TCT 2023

Continuous Non-Invasive Biological Sample Biomarkers for Chronic Disease Monitoring (GPX)

Presenter: Javier Echenique

October 24, 2023

Advertisement

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Overcoming the "Credibility Crisis" of Observational Data

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Four-Year Outcomes From the EVOLUT Low Risk Trial

The FDA Total lifecycle Advisory Program (FDA-TAP)

Understanding the New Technology Add-on Payments Program (NTAP)

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

TCT 725: Blinded 3D Computational Modeling Derived Peak Areal Stretch from Pre-TAVR CT Is Predictive of Aortic Root Rupture Post TAVR

TCT 671: Comparison of Biological and Polymeric Transcatheter Aortic Valves in an Ovine, Aortic Banding Model

Precision Measurement of Neurocognitive Health Based on Ocular Digital Phenotyping

What Should EFS 2.0 Look Like?

TCT 467: DurAVR Biomimetic Transcatheter Aortic Valve: First-In-Human Study Results Update

Cognitive AI and Computer Vision to Detect Acute Cardiac Conditions Using Facial Analysis (MiaVitalis)

MDIC and EFS: The Good, the Bad, and the Ugly (Case Examples)

TCT 374: Redo Transcatheter Aortic Valve Replacement With the Novel DurAVR Valve: Insights From the Bench

Viewpoints From Europe

TCT 262: Rejuvenate: A Novel Anti-Calcific and Anti-Thrombotic Polymeric TAVR With Adaptive Sealing Technology

Continuous Non-Invasive Biological Sample Biomarkers for Chronic Disease Monitoring (GPX)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content